TL;DR
A November 15 MedPage Today commentary by Arthur Lazarus discusses a JAMA Psychiatry study that associated online sports betting legalization with increased use of antidepressant and anti-anxiety medication and more outpatient visits for depression and anxiety among adults with employer-sponsored insurance. The study reports an association, not proof that legalization caused the changes; its scope and the size of the reported effects are not provided in the source material.
A JAMA Psychiatry study linked the legalization of online sports betting with a higher probability of antidepressant and anti-anxiety medication use, as well as more outpatient visits for depression and anxiety, among adults with employer-sponsored insurance. The findings, discussed in a November 15, 2026, MedPage Today commentary by physician Arthur Lazarus, point to possible mental health costs as betting becomes easier to access, but do not establish that legalization caused the changes.
Get workout gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Lazarus, a contributing writer for MedPage Today, describes sports-betting apps as making wagers readily available through phones, with refreshed odds and personalized promotions encouraging repeated engagement. He argues that warning messages in betting advertisements sit alongside marketing that presents wagering as ordinary entertainment. Those observations are the writer’s argument; the supplied report does not provide an independent assessment of advertising practices or specific marketing data.
The study finding cited in the commentary concerns medication use and outpatient care, not a direct count of people diagnosed with gambling disorder. According to Lazarus, researchers found increases in the probability of using antidepressants and anti-anxiety medication and in outpatient visits for depression and anxiety after online sports betting was legalized. The source excerpt gives no numerical estimates, study period, state-by-state breakdown, or details on how the researchers measured legalization and health care use.
Lazarus also describes possible costs that may reach beyond individual bettors, including debt, secrecy, relationship conflict and distress. He says clinicians may encounter gambling-related problems through symptoms such as insomnia, panic, depression, alcohol misuse or suicidal thinking. These are examples from his clinical argument, not outcomes quantified by the study as presented in the material.
Mental Health Costs Beyond the Bet
The finding matters because it connects a change in the availability of a commercial activity with changes in measured mental health care use. It gives policymakers, health professionals and the public a reason to examine whether expanded access and promotion carry costs that are not reflected in betting companies’ revenues or state tax receipts. The association alone cannot answer that question, but it makes the health effects relevant to debates about how online betting is regulated.
Lazarus argues that any costs may be shared: bettors can lose money, while families and health services may face the effects of financial strain and distress. He questions whether public budgets should depend on gambling revenue when that revenue is generated from wagers and losses. The commentary offers this as an ethical and policy concern; it does not estimate the share of state revenue involved or establish how losses are distributed.
For clinicians, the practical point is that gambling-related distress may not be identified as gambling in a medical visit. Lazarus calls for clinicians to speak in policy and public health discussions and to recognize possible gambling-related concerns in patients presenting with mental health or financial stress. The source does not set out a screening protocol or make a recommendation from the study authors.
Products Worth Considering

Garmin Venu 3S GPS Fitness Smartwatch, 41 mm, French Gray

LEVOIT Vital 200S-P Smart Air Purifier for Large Rooms, White

Therabody Theragun Relief Massage Gun, 3-Speed, Navy
As an affiliate, we earn on qualifying purchases.
From Legal Access to Health Care Use
The cited study examines online sports betting legalization and health care outcomes among adults covered by employer-sponsored insurance. That is a defined population and set of measures. It should not be read as showing that every person who bets will develop a mental health condition, or as describing all bettors, including people without that insurance.
The commentary places the research within a wider debate over the trade-offs of legal, readily available gambling. Lazarus compares that debate with discussions of other consumer products and asks who benefits financially and who may bear the resulting harms. He also notes that sports leagues, media companies, betting platforms and states can receive commercial or tax revenue, while consumers and their families may face losses. The piece is an opinion commentary, not a full investigation of those industries or a comprehensive review of gambling policy.
“The study found that legalization of online sports betting was associated with increases in the probability of antidepressant and anti-anxiety medication use, as well as increased outpatient visits for depression and anxiety among adults with employer-sponsored insurance.”
— Arthur Lazarus, MD, MBA, MedPage Today contributing writer
Study Scope and Causation
The supplied report does not give the study’s authors, publication date, sample size, effect estimates, research period or methods. It also does not explain how researchers accounted for other changes that could affect medication use or outpatient visits. Those details are needed to judge the strength and limits of the findings.
The reported relationship is an association. The material does not establish that legalization caused the increases, nor does it show that the study measured gambling disorder, the amount individuals wagered, or outcomes among people outside employer-sponsored insurance. It is also unclear from the excerpt whether the findings apply equally across states or groups of bettors.
Questions for Policy and Practice
The supplied material does not identify a scheduled policy decision, official response or follow-up study. Lazarus calls for clinicians’ voices in legislative hearings, hospital community-benefit plans, professional society statements, public health campaigns and medical education. Those are proposals in his commentary, not announced actions.
Readers seeking to assess the research should look for the full JAMA Psychiatry paper and its methods, population, time frame and effect estimates. Further evidence would help clarify whether the observed changes reflect a causal effect of legalization, how broadly the results apply, and what role advertising, app design and state policy may play. Until then, the finding is a signal for further scrutiny, not proof of a specific effect on every bettor.
Key Questions
What did the JAMA Psychiatry study report?
As summarized by Arthur Lazarus, the study associated online sports betting legalization with a higher probability of antidepressant and anti-anxiety medication use and more outpatient visits for depression and anxiety among adults with employer-sponsored insurance.
Does the study prove that online betting causes depression or anxiety?
No. The source describes an association, which does not by itself establish that legalization caused the reported changes. The supplied excerpt does not include enough methodological detail to assess causation.
Did the study show that all sports bettors need mental health care?
No such conclusion is reported. The finding concerns changes in medication-use probabilities and outpatient visits in a particular insured population; it does not say that all bettors experience mental health problems.
What details about the research are missing from the report?
The supplied material does not state the study’s sample size, time period, numerical effect estimates, methods or state-level results. It also does not provide findings for people without employer-sponsored insurance.
What does Lazarus say should happen next?
Lazarus argues that clinicians should contribute to legislative hearings, public health campaigns, medical education and other policy discussions. The commentary does not announce a specific government action or a scheduled research follow-up.
Source: medpagetoday.com
